Gregory Fraser
Stock Analyst at Truist Securities
(2.60)
# 2,228
Out of 4,960 analysts
37
Total ratings
51.85%
Success rate
15.13%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Hold | $65 → $77 | $91.01 | -15.39% | 10 | Aug 11, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $220 → $230 | $123.11 | +86.82% | 1 | Mar 6, 2025 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $7.49 | -6.54% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $200 → $160 | $2.25 | +7,011.11% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $3.22 | +179.50% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $9.59 | -27.01% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $70.33 | -58.77% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $12.43 | +664.28% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $7.68 | +134.38% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $15.99 | +150.23% | 2 | May 26, 2023 |
ANI Pharmaceuticals
Aug 11, 2025
Maintains: Hold
Price Target: $65 → $77
Current: $91.01
Upside: -15.39%
Jazz Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $220 → $230
Current: $123.11
Upside: +86.82%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $7.49
Upside: -6.54%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200 → $160
Current: $2.25
Upside: +7,011.11%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $3.22
Upside: +179.50%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $9.59
Upside: -27.01%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $70.33
Upside: -58.77%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $12.43
Upside: +664.28%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $7.68
Upside: +134.38%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $15.99
Upside: +150.23%